Companies · USAspending parent record
ROCHE HOLDING AG
No confirmed stock ticker. 3 recipient records grouped under this USAspending parent (UEI WJHDT127L353).
obligated to date on 11 non-competed awards of $1M+ signed FY2024–26
Not recently updated
Obligated to date, not spending in a year. Selected awards only (rule r5-v1): not this company's not-competed share.
11 non-competed ($1M+) · 8 other ($10M+)
Not recently updated
obligated to date: 75A50325F80003, Department of Health and Human Services, signed FY2025
Not recently updated
No confirmed stock ticker, so no member trades are matched to this company.
Federal contract awards in our records
Each row is one prime contract award on USAspending.gov; “USAspending” opens its official page.
What this table covers: every award signed in FY2024–26 that the agency coded “not competed” and that is $1 million or more, plus any award of $10 million or more (rule r5-v1). Smaller competed awards are not in it, so it is not this company’s total federal business and it cannot show a not-competed share. “Obligated to date” is the total committed on the award so far, including later modifications (USAspending, as of Oct 3, 2026), not the amount at any earlier date.
| Signed in | Non-competed awards | Obligated to date | Other awards $10M+ | Obligated to date |
|---|---|---|---|---|
| FY2024 | 4 | $6.2M | 3 | $57.8M |
| FY2025 | 4 | $6.8M | 4 | $128M |
| FY2026incomplete | 3 | $4.3M | 1 | $22.0M |
FY2026 is incomplete: the Department of Defense reports contract actions 90 days late, and older awards keep growing through modifications, so these amounts will rise. Source: USAspending.gov, as of Oct 3, 2026.
| Source | ||||||
|---|---|---|---|---|---|---|
| 36C10G26F0017Order under IDV 36C10G24D0059TASK ORDER FOR TUMOR MOLECULAR TESTING. | FOUNDATION MEDICINE, INC. | Department of Veterans Affairs | Sep 25, 2026FY2026 | Competed under SAP | $22,000,000 | USAspending |
| HT001426FE065Order under IDV HT001425A0014VENTANA BENCHMARK STAINS, REAGENTS, SUPPORT | ROCHE DIAGNOSTICS CORPORATION | Department of Defense | Jun 1, 2026FY2026 | Not competed under SAPSAP non-competition (FAR 13) | $1,650,362 | USAspending |
| HT001426FE015Order under IDV HT001425A0014PROCUREMENT OF TISSUE STAINING AND PROCESSING CAPABILITIES | ROCHE DIAGNOSTICS CORPORATION | Department of Defense | Jan 27, 2026FY2026 | Not competed under SAPSAP non-competition (FAR 13) | $1,602,294 | USAspending |
| 36C25926N0173Order under IDV 36C25923A0007VISN 19 GENMARK EPLEX REAGENTS AND MAINTENANCE | ROCHE DIAGNOSTICS CORPORATION | Department of Veterans Affairs | Dec 23, 2025FY2026 | Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i)) | $1,051,808 | USAspending |
FY2026 awards to ROCHE HOLDING AG, largest first (obligated to date)
- 36C10G26F0017Order under IDV 36C10G24D0059TASK ORDER FOR TUMOR MOLECULAR TESTING.FOUNDATION MEDICINE, INC.
- Signed
- Sep 25, 2026FY2026
- Competition
- Competed under SAP
- Obligated to date
- $22,000,000
- HT001426FE065Order under IDV HT001425A0014VENTANA BENCHMARK STAINS, REAGENTS, SUPPORTROCHE DIAGNOSTICS CORPORATION
- Agency
- Department of Defense
- Signed
- Jun 1, 2026FY2026
- Competition
- Not competed under SAPSAP non-competition (FAR 13)
- Obligated to date
- $1,650,362
- HT001426FE015Order under IDV HT001425A0014PROCUREMENT OF TISSUE STAINING AND PROCESSING CAPABILITIESROCHE DIAGNOSTICS CORPORATION
- Agency
- Department of Defense
- Signed
- Jan 27, 2026FY2026
- Competition
- Not competed under SAPSAP non-competition (FAR 13)
- Obligated to date
- $1,602,294
- 36C25926N0173Order under IDV 36C25923A0007VISN 19 GENMARK EPLEX REAGENTS AND MAINTENANCEROCHE DIAGNOSTICS CORPORATION
- Signed
- Dec 23, 2025FY2026
- Competition
- Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i))
- Obligated to date
- $1,051,808
Recipient records grouped under this company (3)
USAspending groups recipients by its parent-company field, which has known errors. Check that the recipients below belong to ROCHE HOLDING AG; the stock link below is made per recipient.
- ROCHE DIAGNOSTICS CORPORATION12 awards · 11 non-competed, $17.3M obligated to date
- FOUNDATION MEDICINE, INC.4 awards
- GENENTECH USA, INC3 awards
Stock ticker
Links between a federal contract recipient and an SEC-registered company, made by a written rule from SEC filings and USAspending records. Only confirmed links are shown.
No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant.
Members of Congress who reported trading this stock
No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant. Without a confirmed ticker, no trades are matched to this company.
Looking for agency-level shares? See non-competed share by agency.